Fundraising Fox

Invivo Therapeutics Holdings

Cambridge, US · Nevada corporation

Biotech

Founders & leadership

RC
Richard ChristopherExecutive
RT
Richard ToselliExecutive
RR
Richard RobertsNamed on SEC filing
RR
Robert RosenthalNamed on SEC filing
CM
Christina MorrisonNamed on SEC filing
DM
Daniel MarshakNamed on SEC filing
CA
C. Ann MerrifieldNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$9.3M disclosed across 2 rounds · 2020–2022

▶$6.2MraisedOct 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert RosenthalDirector
  • Richard RobertsDirector
  • C. Ann MerrifieldDirector
  • Daniel MarshakDirector
  • Christina MorrisonDirector
  • Heather HamelExecutive Officer
  • Richard ChristopherExecutive Officer
  • Richard ToselliExecutive Officer, Director
Offering amount
$6.2M
Amount sold
$6.2M
Sales commissions
$531.3K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Oct 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedApr 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard RobertsDirector
  • Robert RosenthalDirector
  • Richard ChristopherExecutive Officer
  • Christina MorrisonDirector
  • Richard ToselliExecutive Officer, Director
  • Daniel MarshakDirector
  • C. Ann MerrifieldDirector
Offering amount
$3M
Amount sold
$3M
Sales commissions
$255.2K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Apr 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Invivo Therapeutics Holdings raised?
Invivo Therapeutics Holdings has disclosed $9.3M raised across 2 rounds.
Where is Invivo Therapeutics Holdings headquartered?
Invivo Therapeutics Holdings is headquartered in Cambridge, US.